EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Impacto da partição de comprimidos de clonazepam: uma avaliação comparativa.

Maria Eduarda Pereira, Marcelo Antonio Oliveira

Health and Biosciences · 2025

DOI: 10.47456/hb.64.50803 ↗
AbstractBibliografische Angaben

Abstract

Clonazepam (CLO) is the most prescribed drug in the benzodiazepine class, used as an antiepileptic and anxiolytic agent. Tablets are the most commercialized pharmaceutical form in the world. Pill partitioning refers to the practice of dividing a pill into smaller parts to adjust the prescribed dose of a drug, and is a decision related, in most cases, to the flexibility of doses, reduction of the cost of therapy and to facilitate swallowing, presenting a high risk to public health and impacting the quality of the drug. The objective of this study was to evaluate quality aspects of whole and broken tablets containing CLO, according to the Brazilian Pharmacopoeia, to correlate losses after Quality Control tests such as Content, Unit Dose Uniformity, Weight Determination, Friability, Hardness, and to compare the impact of the use of different partitioning methods by the population: knife, hands, and tablet cutter. The tests proved to be adequate to evaluate the quality of the tablets after partitioning, demonstrating that the physical characteristics of the evaluated tablets influence the cut. The loss of quality in all drugs after partitioning was notorious, with increased Friability, reduced Hardness and problems of dose homogeneity (Unit Dose Uniformity Test). In addition, it is possible to determine that the best performing tablets after partitioning were R (reference drug) and G1 (generic drug). Thus, the best method of partitioning the pills according to the research was with the use of one's own hands, but it is not a recommended action.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →